Theralase Technologies Inc.
TLTFF
$0.1305
$0.00251.95%
| Weiss Ratings | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.73 | |||
| Price History | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.48% | |||
| 30-Day Total Return | -23.91% | |||
| 60-Day Total Return | -37.86% | |||
| 90-Day Total Return | -38.59% | |||
| Year to Date Total Return | -31.53% | |||
| 1-Year Total Return | -1.66% | |||
| 2-Year Total Return | -32.94% | |||
| 3-Year Total Return | -49.20% | |||
| 5-Year Total Return | -15.42% | |||
| 52-Week High % Change | -51.67% | |||
| 52-Week Low % Change | 63.12% | |||
| Price | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.27 | |||
| 52-Week Low Price | $0.08 | |||
| 52-Week Low Price (Date) | Aug 12, 2024 | |||
| 52-Week High Price (Date) | Oct 22, 2024 | |||
| Valuation | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 31.90M | |||
| Enterprise Value | 31.91M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -14.84% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 45.00 | |||
| Price/Book (Q) | 22.50 | |||
| Enterprise Value/Revenue (TTM) | 42.48 | |||
| Price | $0.13 | |||
| Enterprise Value/EBITDA (TTM) | -10.62 | |||
| Enterprise Value/EBIT | -10.18 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 256.41M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 699 5273 | |||
| Address | 41 Hollinger Road Toronto, ON M4B 3G4 | |||
| Website | www.theralase.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -417.30% | |||
| Profit Margin | -414.17% | |||
| Management Effectiveness | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -82.71% | |||
| Return on Equity | -- | |||
| Income Statement | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 751.20K | |||
| Total Revenue (TTM) | 751.20K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 401.70K | |||
| EBITDA (TTM) | -3.01M | |||
| EBIT (TTM) | -3.13M | |||
| Net Income (TTM) | -3.11M | |||
| Net Income Avl. to Common (TTM) | -3.11M | |||
| Total Revenue Growth (Q YOY) | 9.69% | |||
| Earnings Growth (Q YOY) | 9.95% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 18.75% | |||
| Balance Sheet | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 186.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.10M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.44M | |||
| Current Ratio (Q) | 1.606 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 2.26M | |||
| Total Current Liabilities (Q) | 685.20K | |||
| Total Debt (Q) | 204.20K | |||
| Total Liabilities (Q) | 819.80K | |||
| Total Common Equity (Q) | 1.44M | |||
| Cash Flow | TLTFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -14.50K | |||
| Cash from Financing (TTM) | 2.62M | |||
| Net Change in Cash (TTM) | 165.80K | |||
| Levered Free Cash Flow (TTM) | -1.52M | |||
| Cash from Operations (TTM) | -2.44M | |||
